RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • A balloon for obesity: an option between medication and surgery?

    A balloon for obesity: an option between medication and surgery?
    For many struggling with obesity, taking one of the newly approved prescription medications for weight loss (marketed as Qsymia, Belviq and Contrave) feels like climbing a mountain with a walking cane — it's a little help, but not enough. And...
  • Oklahoma Supreme Court puts abortion restriction on hold

    The Oklahoma Supreme Court on Tuesday temporarily put on hold a state law restricting abortions while the issue is argued in a lower court. The unanimous action by the high court means that women in Oklahoma can continue to use the prescription drugs...
  • Allergan loses bid to block Ackman from voting on takeover

    Allergan loses bid to block Ackman from voting on takeover
    Botox maker Allergan Inc. lost its bid to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort. Allergan had accused Ackman's Pershing Square Capital Management...
  • Allergan says a 2nd suitor wants to buy it, adding to takeover drama

    Allergan says a 2nd suitor wants to buy it, adding to takeover drama
    Botox maker Allergan Inc., which has been fighting an unsolicited takeover bid from a Canadian pharmaceutical maker for six months, said in a regulatory filing that a second company is interested in buying it. Allergan did not identify the new...
  • Obamacare Sunshine Act sheds light on $3.5B paid to doctors

     Obamacare Sunshine Act sheds light on $3.5B paid to doctors
    U.S. doctors and teaching hospitals received nearly $3.5 billion from pharmaceutical companies and medical device manufacturers over the last five months of 2013, according to a partial set of data released Tuesday by the federal government. The data...
  • Allergan seeks to bar Bill Ackman from voting amid takeover bid

    Attorneys for Botox maker Allergan Inc. asked a federal judge in Santa Ana on Tuesday to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort. At issue is a $50-...
  • Valeant says it's willing to raise offer for Allergan to $200 a share

    As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm. J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
  • Hospira gets warning from FDA over drug manufacturing violations

    Hospira gets warning from FDA over drug manufacturing violations
    Hospira said Wednesday it received a warning letter from the Food and Drug Administration after an inspection of its Australian manufacturing facility this year identified "significant violations" of drug manufacturing practices. The warning was...
  • Valeant says it's willing to boost offer for Botox maker Allergan

    Valeant says it's willing to boost offer for Botox maker Allergan
    A Canadian company said it is willing to significantly increase its offer for Botox maker Allergan Inc., the latest chapter in the attempted takeover of the Irvine company. Valeant Pharmaceuticals International Inc. said it would be willing to pay up to...
  • Raw deal for AbbVie, but does anyone care?

    Raw deal for AbbVie, but does anyone care?
    AbbVie got hosed on its aborted Shire deal. Let's get that up top. It's also very hard to feel sorry for it. Sure, the North Chicago-based pharmaceutical business failed to score Adderall and the Irish outfit behind it. You can make all the cracks you...
  • Abbott earnings tumble as costs offset better sales

    Abbott earnings tumble as costs offset better sales
    Abbott Laboratories on Wednesday said third-quarter earnings tumbled 44 percent on a tax charge that offset an uptick in sales. The north suburban-based maker of infant formula, medical devices and drugs, said it earned $538 million in the most recent...